alzheimer’s:
Alzheimer’s disease is most common in these US counties, new study finds
Seniors living in the eastern and southeastern parts of the United States have the largest prevalence of Alzheimer’s disease, according ...
Resistance training can alleviate Alzheimer’s disease symptoms, research suggests
Resistance training and physical exercise plays a role in alleviating symptoms of Alzheimer’s disease, researchers suggest. An article published in the ...
FDA fully approves ‘novel’ Alzheimer’s disease drug Leqembi, will be covered by Medicare
The Food and Drug Administration (FDA) has fully approved a “novel” drug used to treat adult patients with Alzheimer’s, the ...
New Alzheimer’s blood test may determine who is at risk of dementia: ‘Could be game changer’
A blood test may help identify individuals at risk for Alzheimer’s before they show any signs of the disease, according ...
AI tool gives doctors personalized Alzheimer’s treatment plans for dementia patients
More than six million Americans are living with Alzheimer’s disease — and one in three seniors dies with the disease, ...
In Alzheimer’s study, sleeping pills are shown to reduce signs of disease in the brain
Sleep difficulties are a common complaint among those living with Alzheimer’s disease — and experts say those challenges often start ...
Early Alzheimer’s disease could be diagnosed through eye exams, new study suggests
Alzheimer’s is a disease of the brain, usually diagnosed through MRI scans and a battery of other tests. Researchers, however, have ...
Alzheimer’s diagnoses expected to reach nearly 13 million by 2050, says new report
An estimated 6.7 million Americans are living with Alzheimer’s disease today — about one in every nine people age 65 ...
Mediterranean, MIND diets shown to reduce signs of Alzheimer’s in the brain, study finds
Those who follow the Mediterranean and MIND diets could be at a lower risk of developing Alzheimer’s disease, a recent ...
FDA accelerates approval for Alzheimer’s drug
The Food and Drug Administration on Friday announced the fast-tracked approval of an Alzheimer’s drug that modestly slows the brain-robbing ...
